Peraza Lisa (CIK 0001828266)

Latest company ownership

HRTX - HERON THERAPEUTICS, INC. /DE/
Role: VP, Chief Accounting Officer
Shares held
6,846
Last filed at
Jan 19, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 13, 2024 Jan 16, 2024 HERON THERAPEUTICS, INC. /DE/ VP, Chief Accounting Officer Sell 47.5 -756 -1.33% ✗ $1.6K
Jul 25, 2023 Oct 17, 2023 HERON THERAPEUTICS, INC. /DE/ VP, Chief Accounting Officer Sell 46.3 -15,603 -12.62% ✗ $22.9K
Jul 13, 2023 Jul 17, 2023 HERON THERAPEUTICS, INC. /DE/ VP, Chief Accounting Officer Sell 47.5 -860 -3.29% ✗ $1.1K
Apr 13, 2023 Apr 17, 2023 HERON THERAPEUTICS, INC. /DE/ VP, Chief Accounting Officer Sell 47.5 -860 -3.50% ✗ $2.5K
Jan 13, 2023 Jan 17, 2023 HERON THERAPEUTICS, INC. /DE/ VP, Chief Accounting Officer Sell 47.5 -1,013 -4.39% ✗ $3.2K
Oct 13, 2022 Oct 17, 2022 HERON THERAPEUTICS, INC. /DE/ VP, Chief Accounting Officer Sell 47.5 -861 -4.01% ✗ $3.2K
Jul 13, 2022 Jul 15, 2022 HERON THERAPEUTICS, INC. /DE/ VP, Chief Accounting Officer Sell 47.5 -860 -4.34% ✗ $2.6K
Apr 13, 2022 Apr 15, 2022 HERON THERAPEUTICS, INC. /DE/ VP, Chief Accounting Officer Sell 47.5 -860 -4.73% ✗ $5.2K
Jan 13, 2022 Jan 14, 2022 HERON THERAPEUTICS, INC. /DE/ VP, Chief Accounting Officer Sell 47.5 -966 -5.79% ✗ $8K
Oct 13, 2021 Oct 15, 2021 HERON THERAPEUTICS, INC. /DE/ VP, Chief Accounting Officer Sell 47.5 -191 -1.33% ✗ $2K
Apr 30, 2021 Jul 15, 2021 HERON THERAPEUTICS, INC. /DE/ VP, Chief Accounting Officer Buy 86.3 +1,339 5.16% ✗ $18.7K
Apr 13, 2021 Apr 15, 2021 HERON THERAPEUTICS, INC. /DE/ VP, Chief Accounting Officer Sell 47.5 -191 -1.57% ✗ $3.2K
Jan 13, 2021 Jan 15, 2021 HERON THERAPEUTICS, INC. /DE/ VP, Chief Accounting Officer Sell 47.5 -227 -1.92% ✗ $4.1K